E2 Sanitizing Hand


Kutol Products Company
Human Otc Drug
NDC 50865-017
E2 Sanitizing Hand is a human otc drug labeled by 'Kutol Products Company'. National Drug Code (NDC) number for E2 Sanitizing Hand is 50865-017. This drug is available in dosage form of Soap. The names of the active, medicinal ingredients in E2 Sanitizing Hand drug includes Benzalkonium Chloride - .003 mg/mL . The currest status of E2 Sanitizing Hand drug is Active.

Drug Information:

Drug NDC: 50865-017
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: E2 Sanitizing Hand
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: E2 Sanitizing Hand
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Kutol Products Company
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Soap
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:BENZALKONIUM CHLORIDE - .003 mg/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 15 Sep, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 07 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333A
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:KUTOL PRODUCTS COMPANY
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0686702017074
0686702017098
UPC stands for Universal Product Code.
UNII:F5UM2KM3W7
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
50865-017-03209000 mL in 1 DRUM (50865-017-03)15 Sep, 2015N/ANo
50865-017-074000 mL in 1 BOTTLE, PLASTIC (50865-017-07)15 Sep, 2015N/ANo
50865-017-094000 mL in 1 BOTTLE, PLASTIC (50865-017-09)15 Sep, 2015N/ANo
50865-017-411000 mL in 1 BAG (50865-017-41)15 Sep, 2015N/ANo
50865-017-65800 mL in 1 BAG (50865-017-65)15 Sep, 2015N/ANo
50865-017-672000 mL in 1 BOTTLE, PLASTIC (50865-017-67)15 Sep, 2015N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antibacterial agent

Product Elements:

E2 sanitizing hand e2 sanitizing hand water cocamidopropyl betaine cocamidopropyl pg-dimonium chloride phosphate peg-6 cocamide hydroxyethyl cellulose (280 mpa.s at 2%) laurtrimonium chloride methylisothiazolinone iodopropynyl butylcarbamate benzalkonium chloride benzalkonium

Indications and Usage:

Uses for handwashing to help reduce bacteria on the skin that could cause disease.

Warnings:

Warnings for external use only. avoid contact with eyes. if contact occurs, flush with water. stop use and ask a doctor if, in rare instances, redness or irritation develops and persists for more than 72 hours. keep out of reach of children. if swallowed, contact a physician or poison control center.

Dosage and Administration:

Directions to decrease bacteria on skin, apply small amount, covering hands with product for 30 seconds. add water, lather, rinse.

Stop Use:

Stop use and ask a doctor if, in rare instances, redness or irritation develops and persists for more than 72 hours.

Package Label Principal Display Panel:

1703 label 1703 label

1707 label 1707 label

1709 label 1709 label

1765 label 1765 label

1767 label 1767 label

Further Questions:

Kutol product co. cincinnati, oh 45241 www.kutol.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.